dc.contributor.author |
Guevara-Canales, Janet-Ofelia |
|
dc.contributor.author |
Morales-Vadillo, Rafael |
|
dc.contributor.author |
Sacsaquispe-Contreras, Sonia-Julia |
|
dc.contributor.author |
Barrionuevo-Cornejo, Carlos |
|
dc.contributor.author |
Montes-Gil, Jaime |
|
dc.contributor.author |
Cava-Vergiú, Carlos-Enrique |
|
dc.contributor.author |
Soares, Fernando-Augusto |
|
dc.contributor.author |
Chaves-Netto, Henrique-De-Miranda |
|
dc.contributor.author |
Chaves, Maria-Gracas-Afonso-Miranda |
|
dc.date.accessioned |
2022-01-04T20:31:45Z |
|
dc.date.available |
2022-01-04T20:31:45Z |
|
dc.date.issued |
2013 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/10604 |
|
dc.description.abstract |
Objective: To identify the overall survival and prognostic factors of malignant lymphoma of the oral cavity and the maxillofacial region. Study Design: Clinical records data were obtained in order to determine overall survival at 2 and 5 years, the individual survival percentage of each possible prognostic factor with the actuarial technique, and the survival regarding the possible prognostic factors with the actuarial technique and the Log-rank and Cox’s regression tests. Results: Of 151 subjects, an overall survival was 60% at 2 years, and 45% at 5 years. The multivariate analysis demonstrated statistically significant differences for clinical stage (p=0.002), extranodal involvement (p=0.030), presence of human immunodeficiency virus (p=0.032), and presence of Epstein-Barr virus (p=0.010). Conclusion: The advanced clinical stage and the larger number of involved extranodular sites are related to a lower overall survival, as well as, the presence of previous infections such as the human immunodeficiency and the Epstein-Barr virus. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Medicina Oral |
|
dc.relation.ispartofseries |
Medicina Oral, Patologia Oral y Cirugia Bucal |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
Lymphoma |
en_US |
dc.subject |
oral cavity |
en_US |
dc.subject |
survival |
en_US |
dc.title |
Malignant lymphoma of the oral cavity and the maxillofacial region: Overall survival prognostic factors |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.4317/medoral.18903 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.02.14 |
|
dc.relation.issn |
1698-6946 |
|